Physician

David A Winand, MD

According to 2025 Medicare claims, David Winand, MD (NPI: 1467433284) practices peripheral vascular disease in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is ADVANCED VEIN AND LASER CENTER LANCASTER, LLC (NPI: 1437525490; TIN: 473802552) and primary practice location at 17601-2745.

Winand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 115 traditional Medicare patients, billed 648 HCPCS/CPT codes, and received $250,942 in Medicare payments. The top billing code was 36465 (Injection of chemical agent into single incompetent vein of leg using ultrasound guidance). Part D data shows 12 prescription claims totaling $45 in drug costs. Open Payments data shows 4 records totaling $104. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $140,097 to $250,942. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $2,207 to $45. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$137K$275K2015 Medicare payment: $140,097 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $78,017 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $112,523 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $193,186 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $134,653 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $155,733 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $274,901 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $270,885 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $237,947 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $250,942 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154181,063$140,097
201681366$78,017
201763544$112,523
2018117781$193,186
2019136623$134,653
202089509$155,733
2021129666$274,901
2022129736$270,885
2023124650$237,947
2024115648$250,942

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1K$2.2K2015 Drug cost: $2,207 (USD; Tot_Drug_Cst)2016 Drug cost: $203 (USD; Tot_Drug_Cst)2017 Drug cost: $46 (USD; Tot_Drug_Cst)2018 Drug cost: $1,080 (USD; Tot_Drug_Cst)2019 Drug cost: $961 (USD; Tot_Drug_Cst)2020 Drug cost: $112 (USD; Tot_Drug_Cst)2024 Drug cost: $45 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201553110$2,207
20163035$203
20172831$46
20182530$1,080
20191317$961
2020N/R11$112
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R12$45

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
36465Injection of chemical agent into single incompetent vein of leg using ultrasound guidance40149$870
36475Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance3562$716
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more3939$121
93970Ultrasound study of arm or leg veins with compression and maneuvers83127$113
93971Ultrasound study of one arm or leg veins with compression and maneuvers63153$81

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$104Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David A. Winand, MD?

Tedicare shows public-source Medicare data for David A. Winand, MD (NPI 1467433284), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Winand, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David A. Winand, MD?

David A. Winand, MD is linked to ADVANCED VEIN AND LASER CENTER LANCASTER, LLC (billing NPI 1437525490) in the available physician profile data.

Does David A. Winand, MD have Open Payments data?

David A. Winand, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.